0000950170-24-075633.txt : 20240620
0000950170-24-075633.hdr.sgml : 20240620
20240620163005
ACCESSION NUMBER: 0000950170-24-075633
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240620
DATE AS OF CHANGE: 20240620
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Mereo BioPharma Group plc
CENTRAL INDEX KEY: 0001719714
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38452
FILM NUMBER: 241056693
BUSINESS ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
BUSINESS PHONE: 4403330237300
MAIL ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
FORMER COMPANY:
FORMER CONFORMED NAME: Mereo Biopharma Group plc
DATE OF NAME CHANGE: 20171016
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fox Christine Ann
CENTRAL INDEX KEY: 0002005755
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O MEREO BIOPHARMA
STREET 2: 1 CAVENDISH PLACE
CITY: LONDON
STATE: X0
ZIP: W1G 0QF
FORMER COMPANY:
FORMER CONFORMED NAME: Fox Chrisitne Ann
DATE OF NAME CHANGE: 20231222
144
1
primary_doc.xml
144
0002005755
XXXXXXXX
LIVE
0001719714
Mereo BioPharma Group plc
001-38452
4th Floor, One Cavendish Place
London
X0
W1G 0QF
44-333 023 7300
Fox Christine Ann
Officer
American Depositary Shares Representing Ordinary Shares
Morgan Stanley International, plc
20 Bank Street
Canary Wharf
London
X0
E14 4AD
46672
185754.56
765150254
06/21/2024
Nasdaq
American Depositary Shares Representing Ordinary Shares
06/21/2024
Same Day Cashless Exercise and Sale
Issuer
N
90000
06/21/2024
Equity Compensation
Y
The number of shares to be sold is in the form of American Depositary Shares ("ADSs"). The number of shares outstanding is in the form of ordinary shares. Each ADS represents 5 ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Represents ADSs sold to cover tax obligations from vesting of Performance Based Restricted Share Units.
06/20/2024
/s/ Christine Ann Fox